These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30412506)

  • 21. New Sensor and Wearable Technologies to Aid in the Diagnosis and Treatment Monitoring of Parkinson's Disease.
    Monje MHG; Foffani G; Obeso J; Sánchez-Ferro Á
    Annu Rev Biomed Eng; 2019 Jun; 21():111-143. PubMed ID: 31167102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A system for inference of spatial context of Parkinson's disease patients.
    Takač B; Català A; Cabestany J; Chen W; Rauterberg M
    Stud Health Technol Inform; 2012; 177():126-31. PubMed ID: 22942043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial.
    Lipsmeier F; Taylor KI; Kilchenmann T; Wolf D; Scotland A; Schjodt-Eriksen J; Cheng WY; Fernandez-Garcia I; Siebourg-Polster J; Jin L; Soto J; Verselis L; Boess F; Koller M; Grundman M; Monsch AU; Postuma RB; Ghosh A; Kremer T; Czech C; Gossens C; Lindemann M
    Mov Disord; 2018 Aug; 33(8):1287-1297. PubMed ID: 29701258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards remote monitoring of Parkinson's disease tremor using wearable motion capture systems.
    Delrobaei M; Memar S; Pieterman M; Stratton TW; McIsaac K; Jog M
    J Neurol Sci; 2018 Jan; 384():38-45. PubMed ID: 29249375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Point of view: Wearable systems for at-home monitoring of motor complications in Parkinson's disease should deliver clinically actionable information.
    Ghoraani B; Galvin JE; Jimenez-Shahed J
    Parkinsonism Relat Disord; 2021 Mar; 84():35-39. PubMed ID: 33549914
    [No Abstract]   [Full Text] [Related]  

  • 26. Wearable Sensors for Advanced Therapy Referral in Parkinson's Disease.
    Heldman DA; Giuffrida JP; Cubo E
    J Parkinsons Dis; 2016 Jul; 6(3):631-8. PubMed ID: 27392872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Wearable Devices for Movement Monitoring of Patients with Parkinson’s Disease].
    Li L; Yu Q; Xu B; Bai Q; Zhang Y; Zhang H; Mao C; Liu C; Wang S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Dec; 33(6):1183-90. PubMed ID: 29715417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Actigraphy monitoring of symptoms in patients with Parkinson's disease.
    Pan W; Kwak S; Li F; Wu C; Chen Y; Yamamoto Y; Cai D
    Physiol Behav; 2013 Jul; 119():156-60. PubMed ID: 23748129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double closed loop to enhance the quality of life of Parkinson's Disease patients: REMPARK system.
    Samà A; Pérez-López C; Rodríguez-Martín D; Moreno-Aróstegui JM; Rovira J; Ahlrichs C; Castro R; Cevada J; Graça R; Guimarães V; Pina B; Counihan T; Lewy H; Annicchiarico R; Bayés A; Rodríguez-Molinero A; Cabestany J
    Stud Health Technol Inform; 2014; 207():115-24. PubMed ID: 25488217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Objective measurement of motor activity in Parkinson's disease by actigraphy. Clinical assessment of akinesia].
    Fujikane M; Katayama S; Hirata K; Yokota N
    Nihon Rinsho; 1997 Jan; 55(1):153-7. PubMed ID: 9014441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gait assessment in Parkinson's disease patients through a network of wearable accelerometers in unsupervised environments.
    Cancela J; Pastorino M; Arredondo MT; Pansera M; Pastor-Sanz L; Villagra F; Pastor MA; Gonzalez AP
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():2233-6. PubMed ID: 22254784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinect4FOG: monitoring and improving mobility in people with Parkinson's using a novel system incorporating the Microsoft Kinect v2.
    Amini A; Banitsas K; Young WR
    Disabil Rehabil Assist Technol; 2019 Aug; 14(6):566-573. PubMed ID: 29790385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD_Manager): study protocol for a pilot randomised controlled trial.
    Antonini A; Gentile G; Giglio M; Marcante A; Gage H; Touray MML; Fotiadis DI; Gatsios D; Konitsiotis S; Timotijevic L; Egan B; Hodgkins C; Biundo R; Pellicano C;
    Trials; 2018 Sep; 19(1):492. PubMed ID: 30217235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the Parkinson's KinetiGraph in monitoring and managing Parkinson's disease.
    Farzanehfar P; Horne M
    Expert Rev Med Devices; 2017 Aug; 14(8):583-591. PubMed ID: 28675078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Parameters and Tools for Home-Based Assessment of Parkinson's Disease: Results from a Delphi study.
    Ferreira JJ; Santos AT; Domingos J; Matthews H; Isaacs T; Duffen J; Al-Jawad A; Larsen F; Artur Serrano J; Weber P; Thoms A; Sollinger S; Graessner H; Maetzler W
    J Parkinsons Dis; 2015; 5(2):281-90. PubMed ID: 25663101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A computational framework for the standardization of motion analysis exploiting wearable inertial sensors.
    Turcato A; Ramat S
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():4963-6. PubMed ID: 22255452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes.
    Antonini A; Yegin A; Preda C; Bergmann L; Poewe W;
    Parkinsonism Relat Disord; 2015 Mar; 21(3):231-5. PubMed ID: 25585993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of motor fluctuations on real-life gait in Parkinson's patients.
    Silva de Lima AL; Evers LJW; Hahn T; de Vries NM; Daeschler M; Boroojerdi B; Terricabras D; Little MA; Bloem BR; Faber MJ
    Gait Posture; 2018 May; 62():388-394. PubMed ID: 29627498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time for a strategy in night-time dopaminergic therapy? An objective sensor-based analysis of nocturnal hypokinesia and sleeping positions in Parkinson's disease.
    Sringean J; Anan C; Thanawattano C; Bhidayasiri R
    J Neurol Sci; 2017 Feb; 373():244-248. PubMed ID: 28131197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multilevel Features for Sensor-Based Assessment of Motor Fluctuation in Parkinson's Disease Subjects.
    Ghoraani B; Hssayeni MD; Bruack MM; Jimenez-Shahed J
    IEEE J Biomed Health Inform; 2020 May; 24(5):1284-1295. PubMed ID: 31562114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.